ClinicalTrials.Veeva

Menu

Repeatability of Electroretinogram and Visual Evoked Potential

B

Benha University

Status

Unknown

Conditions

Vision Disorders
Visual Impairment
Retinal Disease

Treatments

Diagnostic Test: Electroretinogram (ERG)
Diagnostic Test: Visual evoked potential (VEP)

Study type

Interventional

Funder types

Other

Identifiers

NCT05334875
RC 8-22

Details and patient eligibility

About

To assess repeatability of electroretinogram and visual evoked potential in clinical practice

Full description

To assess repeatability of electroretinogram in evaluation of retinal function and visual evoked potential in evaluation of visual pathway in clinical practice.

Enrollment

250 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Normal subjects visit banha university hospital seeking regular checkup and subjects asked for ERG and VEP as a pre-occupational examination.

Exclusion criteria

  • Patients previously diagnosed with any retinal disease or visual pathway disease that may affect ERG and VEP tests.

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

250 participants in 2 patient groups

Electroretinogram test (ERG)
Active Comparator group
Description:
ERG test will be done for each subject twice and compare the results to assess repeatability of the test.
Treatment:
Diagnostic Test: Electroretinogram (ERG)
Visual evoked potential test (VEP)
Active Comparator group
Description:
VEP test will be done for each subject twice and compare the results to assess repeatability of the test.
Treatment:
Diagnostic Test: Visual evoked potential (VEP)

Trial contacts and locations

1

Loading...

Central trial contact

Ahmed Abdelshafy, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems